title: Does topical brimonidine tartrate help NAION?
authors.forename: H E
authors.initials: HE
authors.lastname: Fazzone
authors.forename: M J
authors.initials: MJ
authors.lastname: Kupersmith
authors.forename: J
authors.initials: J
authors.lastname: Leibmann
mesh_terms: D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000068438:Brimonidine Tartrate; D003117:Color Vision Defects / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D009883:Ophthalmic Solutions; D018917:Optic Neuropathy, Ischemic / Q000150:complications / Q000188:drug therapy*; D011810:Quinoxalines / Q000008:administration & dosage*; D012189:Retrospective Studies; D017211:Treatment Failure; D014786:Vision Disorders / Q000188:drug therapy / Q000209:etiology; D014792:Visual Acuity
chemical_list: D000316:Adrenergic alpha-Agonists; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate